Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multi-omics characterization of the skin microbiota reveals the anti-aging roles of Stenotrophomonas maltophilia.

Microbiome·2026

Same author

MoleculeFormer is a GCN-transformer architecture for molecular property prediction.

Communications biology·2025

Same author

PersADE: a database of personalized adverse drug events and their underlying molecular mechanisms.

Nucleic acids research·2025

Same author

Dynamic clinical trial success rates for drugs in the 21st century.

Nature communications·2025

Same author

Microllm: a structured information extraction tool using large language models and named entity recognition in microbiology.

Briefings in bioinformatics·2025

Same author

A comprehensive reference catalog of human skin DNA virome reveals novel viral diversity and microenvironmental influences.

Microbiology spectrum·2025

Search research articles

Related Experiment Video

Updated: Jun 30, 2026

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

Developing and validating predictive decision tree models from mining chemical structural fingerprints and

Lianyi Han¹, Yanli Wang, Stephen H Bryant

¹National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA. hanl@ncbi.nlm.nih.gov

BMC Bioinformatics

|September 27, 2008

Summary

Decision Trees (DT) models effectively filter high-throughput screening (HTS) data for drug discovery. These computational models enhance hit selection by analyzing compound bioactivities and chemical structures.

Related Experiment Videos

Last Updated: Jun 30, 2026

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

Area of Science:

Computational chemistry
Cheminformatics
Drug discovery

Background:

High-throughput screening (HTS) generates vast amounts of data, posing challenges for drug development research.
Computational approaches are needed to efficiently analyze HTS results and manage large, potentially erroneous datasets.

Purpose of the Study:

To develop and evaluate Decision Trees (DT) based models for discriminating compound bioactivities.
To assess the utility of DT models in filtering biological activity data from PubChem BioAssay Database.

Main Methods:

Utilized chemical structure fingerprints from PubChem to build DT models.
Applied 10-fold Cross Validation (CV) to evaluate model performance, measuring sensitivity, specificity, and Matthews Correlation Coefficient (MCC).
Validated DT models on independent bioassays for HIV-1 RT-RNase H inhibitors, calculating enrichment factors.

Main Results:

DT models demonstrated promising performance with CV sensitivity (57.2–80.5%), specificity (97.3–99.0%), and MCC (0.4–0.5).
Enrichment factors of 4.4 and 9.7 were achieved when evaluating DT models on independent HIV RNase inhibitor screening datasets.
The models successfully discriminated compound bioactivities for various assays, including 5HT1a agonists/antagonents and HIV-1 RT-RNase H inhibitors.

Conclusions:

The developed DT models serve as a valuable virtual screening technique.
DT models can effectively complement traditional methods for selecting potential drug hits from HTS data.